Internal Medicine Residency Training Program, Oman Medical Specialty Board, Muscat 130, Oman.
Department of Medicine, Sultan Qaboos University Hospital, Muscat 123, Oman.
Medicina (Kaunas). 2023 Jul 23;59(7):1347. doi: 10.3390/medicina59071347.
: Constipation is a prevalent gastrointestinal condition that has a substantial impact on individuals and healthcare systems. This condition adversely affects health-related quality of life and leads to escalated healthcare expenses due to an increase in office visits, referrals to specialists, and hospital admission. This study aimed to evaluate the prevalence, recognition, risk factors, and course of constipation among hospitalized patients in medical wards. A prospective study was conducted, including all adult patients admitted to the General Medicine Unit between 1 February 2022 and 31 August 2022. Constipation was identified using the Constipation Assessment Scale (CAS), and relevant factors were extracted from the patients' medical records. Among the patients who met the inclusion criteria (n = 556), the prevalence of constipation was determined to be 55.6% (95% CI 52.8-58.4). Patients with constipation were found to be older ( < 0.01) and had higher frailty scores ( < 0.01). Logistic regression analysis revealed that heart failure (Odds ratio (OR) 2.1; 95% CI 1.2-3.7; = 0.01), frailty score (OR 1.4; 95% CI 1.2-1.5; < 0.01), and dihydropyridines calcium channel blockers (OR 1.8; 95% CI 1.2-2.8; < 0.01) were independent risk factors for constipation. Furthermore, the medical team did not identify constipation in 217 patients (64.01%). Constipation is highly prevalent among medically hospitalized patients. To ensure timely recognition and treatment, it is essential to incorporate a daily constipation assessment scale into each patient's medical records.
便秘是一种普遍的胃肠道疾病,对个人和医疗保健系统都有重大影响。这种疾病会对健康相关的生活质量产生不利影响,并导致医疗费用增加,因为就诊次数、专科转介和住院治疗增加。本研究旨在评估住院患者在医学病房中便秘的患病率、识别率、危险因素和病程。
本研究为前瞻性研究,纳入 2022 年 2 月 1 日至 2022 年 8 月 31 日期间入住普通内科病房的所有成年患者。使用便秘评估量表(Constipation Assessment Scale,CAS)来识别便秘,从患者的病历中提取相关因素。
在符合纳入标准的患者中(n=556),便秘的患病率为 55.6%(95%CI 52.8-58.4)。便秘患者年龄较大(<0.01),衰弱评分较高(<0.01)。Logistic 回归分析显示,心力衰竭(比值比(Odds ratio,OR)2.1;95%CI 1.2-3.7;=0.01)、衰弱评分(OR 1.4;95%CI 1.2-1.5;<0.01)和二氢吡啶类钙通道阻滞剂(OR 1.8;95%CI 1.2-2.8;<0.01)是便秘的独立危险因素。此外,医疗团队在 217 名患者(64.01%)中未识别出便秘。
便秘在住院患者中普遍存在。为了确保及时识别和治疗,有必要在每位患者的病历中纳入每日便秘评估量表。